Roshni Roy

Title: Roshni Roy: Innovator in Colorectal Cancer Treatment

Introduction

Roshni Roy is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of colorectal cancer. Her innovative work focuses on utilizing biomarker expression to improve patient outcomes.

Latest Patents

Roshni Roy holds a patent titled "Methods for diagnosing, prognosing, and treating colorectal cancer using biomarker expression." This patent addresses the dysregulated expression of microRNAs (miRNAs), which has become a hallmark feature in human cancers. The methods disclosed in her patent aim to select optimal therapy for patients from various treatment options. This is crucial in overcoming the clinical challenge of identifying which patients will benefit from specific therapeutic regimens, especially in metastatic and adjuvant settings. Despite the increase in anti-cancer drugs and multi-drug combinations over the past decade, treatments are often applied using a trial-and-error approach. Roshni's methods and compositions provide a more targeted approach to determining the best treatment options for cancer patients.

Career Highlights

Roshni Roy is affiliated with the Baylor Research Institute, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer treatment protocols and improve patient care.

Collaborations

Roshni collaborates with esteemed colleagues, including Ajay Goel and Raju Kandimalla, who contribute to her research initiatives and enhance the impact of her work.

Conclusion

Roshni Roy's innovative contributions to colorectal cancer treatment exemplify the importance of research in improving patient outcomes. Her patent and ongoing work at the Baylor Research Institute highlight her commitment to advancing medical science and providing better therapeutic options for cancer patients.